AOJNMB is indexed in Pubmed Central from the first issue

1. Schuster DM, Nanni C, Fanti S. Evaluation of prostate cancer with radiolabeled amino acid analogs. J Nucl Med. 2016;57(Suppl 3):61S-6.
2. Bailey DL, Hennessy TM, Willowson KP, Henry EC,Chan DL, Aslani A, et al. In vivo quantification of (177)Lu with planar whole-body and SPECT/CT gamma camera imaging. EJNMMI Phys. 2015;2(1):20.
3. Jalilian AR, Beiki D, Hassanzadeh-Rad A, Eftekhari A, Geramifar P, Eftekhari M. Production and clinical applications of radiopharmaceuticals and medical radioisotopes in Iran. Semin Nucl Med. 2016;46(4):340-58.
4. Mirzaei A, Jalilian AR, Badbarin A, Mazidi M,Mirshojaei F, Geramifar P, et al. Optimized production and quality control of (68)Ga-EDTMP for smallclinical trials. Ann Nucl Med. 2015;29(6):506-11.
5. Ono M, Oka S, Okudaira H, Nakanishi T, Mizokami A, Kobayashi M, et al. [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells. Nucl Med Biol. 2015;42(11):887-92.
6. Jadvar H, Chen K, Ukimura O. Targeted Prostate gland biopsy with combined transrectal ultrasound, mpMRI, and 18F-FMAU PET/CT. Clin Nucl Med.2015;40(8):e426-8.